Rappel de Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM)

Selon Department of Health, Therapeutic Goods Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à Australia qui a été fabriqué par Medtronic Australasia Pty Ltd.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
  • ID de l'événement
  • Classe de risque de l'événement
    Class II
  • Date de mise en oeuvre de l'événement
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Notes supplémentaires dans les données
  • Cause
    Medtronic has identified that due to the sensitivity of an algorithm used in the reveal linq icm, the recommended replacement time (rrt) alert may be prematurely triggered in some devices. the rrt alert is an indicator for when the reveal linq device should be replaced, therefore the premature alarm indicates replacement before it is necessary. this matter does not impact the ability for the reveal linq device to safely continue collecting data. manual data transmissions may also still continue. device battery capacity is not affected. medtronic has not received any reports of patient complications or injury related to this issue. medtronic has observed an occurrence rate of 0.45% of devices experiencing this issue.
  • Action
    Medtronic is advising clinicians that prophylactic device replacement is not recommended unless the clinician determines the loss of daily wireless transmissions outweighs the potential complications associated with device replacement. If a premature RRT alert is confirmed and EOS status is displayed, options to continue ongoing monitoring include remote manual transmissions or performing an interrogation of the programmer. Medtronic will be providing a software update as a permanent correction. For more information, please see https://www.tga.gov.au/alert/medtronic-reveal-linq-insertable-cardiac-monitor. Thia action has been closed out on 08 Jun 2017


  • Modèle / numéro de série
    Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM)Model Number: LNQ11ARTG Number: 218791
  • Manufacturer


  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source